» Articles » PMID: 25957685

RNA Exosome-regulated Long Non-coding RNA Transcription Controls Super-enhancer Activity

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2015 May 11
PMID 25957685
Citations 262
Authors
Affiliations
Soon will be listed here.
Abstract

We have ablated the cellular RNA degradation machinery in differentiated B cells and pluripotent embryonic stem cells (ESCs) by conditional mutagenesis of core (Exosc3) and nuclear RNase (Exosc10) components of RNA exosome and identified a vast number of long non-coding RNAs (lncRNAs) and enhancer RNAs (eRNAs) with emergent functionality. Unexpectedly, eRNA-expressing regions accumulate R-loop structures upon RNA exosome ablation, thus demonstrating the role of RNA exosome in resolving deleterious DNA/RNA hybrids arising from active enhancers. We have uncovered a distal divergent eRNA-expressing element (lncRNA-CSR) engaged in long-range DNA interactions and regulating IgH 3' regulatory region super-enhancer function. CRISPR-Cas9-mediated ablation of lncRNA-CSR transcription decreases its chromosomal looping-mediated association with the IgH 3' regulatory region super-enhancer and leads to decreased class switch recombination efficiency. We propose that the RNA exosome protects divergently transcribed lncRNA expressing enhancers by resolving deleterious transcription-coupled secondary DNA structures, while also regulating long-range super-enhancer chromosomal interactions important for cellular function.

Citing Articles

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X Cell Death Discov. 2025; 11(1):84.

PMID: 40032852 PMC: 11876437. DOI: 10.1038/s41420-025-02366-3.


Epidermal stem cell derived exosomes-induced dedifferentiation of myofibroblasts inhibits scarring via the miR-203a-3p/PIK3CA axis.

Zhao S, Kong H, Qi D, Qiao Y, Li Y, Cao Z J Nanobiotechnology. 2025; 23(1):56.

PMID: 39881312 PMC: 11776291. DOI: 10.1186/s12951-025-03157-9.


Pharmacological, computational, and mechanistic insights into triptolide's role in targeting drug-resistant cancers.

Hussain M, Mujwar S, Babu M, Goyal K, Chellappan D, Negi P Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39862263 DOI: 10.1007/s00210-025-03809-5.


Application Strategies of Super-Enhancer RNA in Cardiovascular Diseases.

He Y, Cai Y, Cao Y, Wang Y, Wang J, Ding H Biomedicines. 2025; 13(1).

PMID: 39857701 PMC: 11762524. DOI: 10.3390/biomedicines13010117.


Polycomb protein RYBP facilitates super-enhancer activity.

Hong Y, Dai R, Li X, Xu H, Wei C Mol Med. 2024; 30(1):236.

PMID: 39604829 PMC: 11603947. DOI: 10.1186/s10020-024-01006-3.


References
1.
Hnisz D, Abraham B, Lee T, Lau A, Saint-Andre V, Sigova A . Super-enhancers in the control of cell identity and disease. Cell. 2013; 155(4):934-47. PMC: 3841062. DOI: 10.1016/j.cell.2013.09.053. View

2.
Qian J, Wang Q, Dose M, Pruett N, Kieffer-Kwon K, Resch W . B cell super-enhancers and regulatory clusters recruit AID tumorigenic activity. Cell. 2014; 159(7):1524-37. PMC: 4272762. DOI: 10.1016/j.cell.2014.11.013. View

3.
Kim N, Jinks-Robertson S . Transcription as a source of genome instability. Nat Rev Genet. 2012; 13(3):204-14. PMC: 3376450. DOI: 10.1038/nrg3152. View

4.
Loven J, Hoke H, Lin C, Lau A, Orlando D, Vakoc C . Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013; 153(2):320-34. PMC: 3760967. DOI: 10.1016/j.cell.2013.03.036. View

5.
Sun J, Keim C, Wang J, Kazadi D, Oliver P, Rabadan R . E3-ubiquitin ligase Nedd4 determines the fate of AID-associated RNA polymerase II in B cells. Genes Dev. 2013; 27(16):1821-33. PMC: 3759698. DOI: 10.1101/gad.210211.112. View